Amarantus Therapeutics, Inc.
CNS Protein Therapeutics Completes Name Change to Amarantus Therapeutics, Appoints New CEO Martin D. Cleary
Published in Medical Patent Business Week, November 13th, 2009
CNS Protein Therapeutics, Inc., a privately held biotechnology company developing first-in-class disease-modifying treatments that address the underlying cause of cell death associated with a wide range of diseases, has completed a corporate name change to Amarantus Therapeutics, Inc. ("Amarantus") and appointed prominent biotechnology industry executive, Martin D. Cleary, as Chief Executive Officer. Mr. Cleary succeeds Co-founder Gerald E. Commissiong, who has served as CEO since 2008.
Mr. Commissiong, who will remain with Amarantus as Chief Business Officer, commented, "Derived from the Latin 'amarantus', our corporate name means 'one that does not wither'." The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
More Articles from Medical Patent Business Week
- 22nd Century Limited, LLC
22nd Century Continuing Development of its Smoking Cessation Aid; Independent Review of Clinical Trials Involving Very Low Nicotine Cigarettes is Encouraging - Acacia Research Corporation
Acacia Subsidiary Acquires Rights to Patent Portfolios for MEMS and Chip-Stacking Technologies - ADC / Tyco Electronics
ADC and Tyco Electronics Reach FTTX Licensing Agreement - Allergan, Inc.
Allergan Announces Victory in Brimonidine Patent Infringement Case - Alnylam Pharmaceuticals, Inc.
Alnylam Grants KOKEN License to Kreutzer-Limmer Patents for the RNA Interference RNAi Research Products Market - Aneurysm
Findings from S.S. Gill and co-authors broaden understanding of aneurysm - More from this issue of Medical Patent Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
